Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept versus 5-fluorouracil after filtration surgery for open-angle glaucoma
ChiCTR-IPC-17011900Phase 4Recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Jan 2017
- Modality
- Small Molecules, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of conbercept and fluorouracil in open-angle glaucoma (OAG) (2 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoints: Intraocular pressure, Number of medications and 1 more. Started Jan 2017; status: recruiting.
02
Drugs
conberceptfluorouracil
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on ChiCTR-IPC-17011900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPC-17011900.